Wilson Kirk, president of Flowserve’s FCD division, has filed 43 Form 4s over the past year, all tied to a single ticker: FLS. The pattern is overwhelmingly one of disposition rather than accumulation. Across all filings, Kirk has sold approximately $1.9 million worth of stock, with zero open-market purchases recorded. The only acquisitions on his ledger are routine compensation events—monthly restricted stock grants averaging roughly $900 to $1,400, plus option exercises valued at zero—none of which reflect discretionary buying.
The most decisive activity came in August 2025, when Kirk executed two large open-market sales within four days. On August 8, he sold shares valued at $525,800, followed by a $532,200 sale on August 12, together accounting for over half of his total sell volume. These transactions dwarf the modest grant values he received in the surrounding months, such as the $896.64 award on August 1 and the $942.30 grant in July. The timing suggests a deliberate reduction of exposure, though the filings themselves offer no indication of motive.
Beyond the August sales, Kirk’s other Form 4 activity is largely mechanical. He has exercised options and had shares withheld to cover taxes—$183,768 on February 13, $71,010 on February 15, and $70,636 on February 17—which are automatic consequences of vesting rather than market calls. His most recent filings, a $1,395.16 grant on September 2 and a $956.52 grant on October 1, show no new selling. The net picture is a corporate insider who has monetized a significant position in FLS over the summer while accumulating only through scheduled compensation, leaving a clear sell bias in the trailing twelve-month record.
AI-assisted summary